are investigating this medication as an effective treatment for the early stages of Covid-19.
The researchers tested different types of SSRIs, which included fluoxetine, escitalopram and paroxetine to see how they would fare in reducing the replication of SARS-CoV-2.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Newsdeck: Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian studyJune 18 (Reuters) - Roche's rheumatoid arthritis drug Actemra failed to help patients with early-stage COVID-19 pneumonia in an Italian study, the latest instance in which an anti-inflammatory drug has fallen through in a coronavirus trial.
Source: dailymaverick - 🏆 3. / 84 Read more »